How Much Does Wegovy Cost?
Wegovy's list price runs $1,300-$1,500/month — the highest among semaglutide products. The insurance picture is more complicated than Ozempic because Wegovy is marketed for weight loss, and many plans still exclude anti-obesity medications. Below is what you will actually pay in every scenario we track.
How much does Wegovy cost per month?
Without insurance, Wegovy costs approximately $1,300-$1,500 per month. With commercial insurance that covers it, copays range from $25-$200 per month. The Novo Nordisk savings card can reduce copays for commercially insured patients. Uninsured patients may qualify for the Novo Nordisk Patient Assistance Program at no cost.
The main cost variable is whether your insurance covers anti-obesity medications. Wegovy is FDA-approved for chronic weight management and cardiovascular risk reduction. Plans that cover weight loss drugs generally require prior authorization, BMI documentation, and sometimes step therapy. Plans that exclude anti-obesity medications will deny Wegovy regardless of clinical need.
Pricing
Wegovy Cost Breakdown
Prices are approximate monthly costs as of March 2026 and vary by pharmacy, location, and specific plan. Source: Novo Nordisk.
Scenarios
What You Will Actually Pay for Wegovy
Commercial Insurance That Covers Weight Loss Drugs
If your plan covers anti-obesity medications, Wegovy is typically available after prior authorization. You will need to document your BMI, comorbidities, and possibly complete step therapy with a less expensive drug first. Copays with coverage range from $25-$200/month depending on your plan's tier placement.
Commercial Insurance That Excludes Weight Loss Drugs
Many employer-sponsored plans explicitly exclude anti-obesity medications. In this case, Wegovy will be denied regardless of your BMI or medical necessity. The Wegovy savings card does not help because the plan excludes the drug category. Your options: appeal through your employer's HR department to add AOM coverage, or pay cash/use patient assistance.
Cardiovascular Indication Coverage
Wegovy received FDA approval for cardiovascular risk reduction in patients with established cardiovascular disease. This second indication may open coverage pathways through plans that exclude weight loss drugs but cover cardiovascular medications. Ask your prescriber whether this indication applies to your situation.
Without Any Insurance
Cash price at retail pharmacies is $1,300-$1,500/month. The Novo Nordisk Patient Assistance Program (PAP) provides Wegovy at no cost to qualifying uninsured patients who meet income requirements. This is a separate program from the savings card — it covers the full cost of the medication for eligible patients.
Medicare
Medicare does not currently cover Wegovy for weight loss. There has been legislative interest in adding anti-obesity medication coverage to Medicare, but as of March 2026 it is not covered. The manufacturer savings card does not work with Medicare.
Savings
Wegovy Savings Card & Patient Assistance
Wegovy Savings Card
Available to commercially insured patients (not Medicare, Medicaid, or Tricare). Reduces copays on Wegovy fills. Apply at the Novo Nordisk website or through your prescriber. Does not override a plan exclusion.
Patient Assistance Program
For uninsured patients who meet income eligibility. Provides Wegovy at no cost. Free to apply through Novo Nordisk. Separate from the savings card — designed for patients without any prescription drug coverage.
Comparison
Wegovy vs. Alternatives: Cost Comparison
Was Your Wegovy Denied?
Insurance denials for GLP-1 medications are common but often overturned on appeal. Our Undeniable tool generates AI-powered appeal letters backed by medical evidence.
Wegovy Cost FAQs
How much does Wegovy cost without insurance?
Wegovy costs approximately $1,300-$1,500 per month without insurance. This is the list price set by Novo Nordisk. Cash prices vary slightly between pharmacies but remain in this range regardless of dose — each pen is a monthly supply.
Does insurance cover Wegovy?
Coverage varies widely. Wegovy is FDA-approved for weight loss, and a growing number of commercial plans cover it with prior authorization. However, many plans still exclude anti-obesity medications entirely. Medicare does not cover Wegovy for weight loss. Wegovy also has an FDA-approved cardiovascular indication, which may open additional coverage pathways.
How do I get the Wegovy savings card?
The Novo Nordisk Wegovy Savings Card is available to patients with commercial insurance (not Medicare, Medicaid, or government plans). Apply on the Novo Nordisk website or through your prescriber. The card reduces copays but does not apply if your plan excludes the medication entirely.
Why is Wegovy more expensive than Ozempic?
Wegovy costs more than Ozempic because it is dosed higher (up to 2.4 mg vs. 2 mg) and is marketed as a weight loss drug rather than a diabetes drug. The pharmaceutical pricing reflects the separate clinical trials (STEP program) and FDA approval process for the obesity indication. Both contain semaglutide made by Novo Nordisk.
Disclaimer
Prices shown are approximate and based on publicly available data as of March 2026. Your actual cost depends on your pharmacy, location, insurance plan, and dosage. MedicalRecords.com does not sell medications or provide insurance advice. Verify pricing with your pharmacy and insurer before filling any prescription.
Sources: Novo Nordisk Wegovy Prescribing Information, FDA Drug Approval Documents